Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer’s Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona

Laia Calvó-Perxas,Oriol Turró-Garriga,Joan Vilalta-Franch,Lozano-Gallego M,Rosa de Eugenio,Fabian Marquez,Olga Carmona,Jordi Gich,Anna Manzano,Marta Viñas,Anna Mª Roig,Josep Garre-Olmo

Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer’s Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona

2017

Laia Calvó-Perxas
Oriol Turró-Garriga
Joan Vilalta-Franch
Lozano-Gallego M
Rosa de Eugenio
Fabian Marquez
Olga Carmona
Jordi Gich
Anna Manzano
Marta Viñas
Anna Mª Roig
Josep Garre-Olmo

Background Acetylcholinesterase inhibitors (AChEIs) and the N-methyl d-aspartate-antagonist memantine are indicated for the symptomatic treatment of Alzheimer’s disease (AD).

Keywords:

Memantine
Medical prescription
Disease
Rivastigmine
Physical therapy
Acetylcholinesterase
Dementia
Galantamine
Cohort study
Medicine
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations